Amylyx Pharmaceuticals, Inc. (AMLX) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 1.14B |
| Enterprise Value | 921.66M |
| P/E Ratio | -10.97 |
| PEG Ratio | -0.13 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 6.57 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -7.62 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.51 |
| Return On Equity | -0.56 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -525,000 |
| EBITDA | -144.16M |
| Net Income | -144.74M |
| Diluted EPS | -1.53 |
| Total Cash | 279.77M |
| Total Cash/Share | 2.53 |
| Total Debt | 5.63M |
| Total Debt/Equity | 0.02 |
| Current Ratio | 17.85 |
| Book Value Per Share | 2.47 |
| 52-Week Change | 224.1 |
| 52-Week High | 18.61 |
| 52-Week Low | 4.8 |
| Moving Average 50 Days | 15.18 |
| Moving Average 200 Days | 14.06 |
| Average Volume | 1.22M |
| Shares Outstanding | 83.13M |
| % Held by Institutions | 120.71 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |